Shilpa Medicare Limited (BOM:530549)
323.30
-8.30 (-2.50%)
At close: Feb 12, 2026
Shilpa Medicare Employees
Shilpa Medicare had 998 employees as of March 31, 2025. The number of employees decreased by 9 or -0.89% compared to the previous year.
Employees
998
Change (1Y)
-9
Growth (1Y)
-0.89%
Revenue / Employee
14.36M INR
Profits / Employee
1.50M INR
Market Cap
63.80B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 998 | -9 | -0.89% |
| Mar 31, 2024 | 1,007 | -172 | -14.59% |
| Mar 31, 2023 | 1,179 | -1,703 | -59.09% |
| Mar 31, 2022 | 2,882 | 388 | 15.56% |
| Mar 31, 2021 | 2,494 | 479 | 23.77% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IOL Chemicals and Pharmaceuticals | 2,891 |
| Neuland Laboratories | 1,794 |
| Bajaj HealthCare | 918 |
| Sudeep Pharma | 740 |
| NGL Fine-Chem | 520 |
| Gujarat Themis Biosyn | 221 |
| Influx Healthtech | 163 |
| Shree Ganesh Remedies | 149 |
Shilpa Medicare News
- 4 days ago - Pharma sector stocks today, Feb 9: Marksans Pharma up 5%, Shilpa Medicare jumps 6%, Glenmark rises 1.83% - Business Upturn
- 7 days ago - Shilpa Medicare Ltd (BOM:530549) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic ... - GuruFocus
- 7 days ago - Q3 2026 Shilpa Medicare Ltd Earnings Call Transcript - GuruFocus
- 7 days ago - Shilpa Medicare Q3 Results: Revenue jumps 28.3% YoY to Rs 409.73 crore, net profit up 40.3% - Business Upturn
- 9 days ago - Pharma sector stocks today, Feb 4: Suven Life Sciences jumps 9%, Aarti Drugs falls 6%, Shilpa Medicare up 2.80%, Mankind Pharma down 2.92% - Business Upturn
- 12 days ago - Pharma sector stocks today, Feb 1: Shilpa Medicare rally 8%, Sun Pharma up 3%, Aurobindo Pharma falls 2.21% - Business Upturn
- 16 days ago - Shilpa Medicare shares in focus after subsidiary secures key US FDA orphan drug milestone - Business Upturn
- 2 months ago - Shilpa Medicare receives Initial Authorization for Rotigotine transdermal patch in European - Business Upturn